SCHEMBL6945106

SCHEMBL6945106

CC(C)(C)OC(=O)CC(CC1CCC1)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 2/20 0.40
CTSK P43235 2/20 0.40
LTA4H P09960 1/20 0.38
CPN1 P15169 2/20 0.37
CPB2 Q96IY4 2/20 0.37
BTK Q06187 1/20 0.37
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
CYP2D6 P10635 1/20 0.34
SLC1A3 P43003 1/20 0.33
SLC1A2 P43004 1/20 0.33
SLC1A1 P43005 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
POLB P06746 1/20 0.33
MMP2 P08253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6945110 1.00 CTSS (0.40) CTSSCTSKLTA4HCPN1CPB2
SCHEMBL1915281 0.97 CTSK (0.43) CTSSCTSKLTA4HCPN1CPB2
SCHEMBL1915283 0.97 CTSK (0.43) CTSSCTSKLTA4HCPN1CPB2
SCHEMBL1914687 0.95 CTSK (0.45) CTSSCTSKLTA4HCPN1CPB2
SCHEMBL1704461 0.95 CTSK (0.45) CTSSCTSKLTA4HCPN1CPB2
SCHEMBL13904755 0.94 CTSS (0.42) CTSSCTSKLTA4HCPN1CPB2
SCHEMBL1915008 0.94 CTSS (0.42) CTSSCTSKLTA4HCPN1CPB2
SCHEMBL1914738 0.87 RECQL (0.36) CTSSCTSKLTA4HCPN1CPB2
SCHEMBL1914747 0.87 RECQL (0.36) CTSSCTSKLTA4HCPN1CPB2
SCHEMBL12487978 0.83 CTSK (0.40) CTSSCTSKLTA4HCYP2D6HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011151434-A1 NOVEL COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING METABOLIC DISORDERS EUROSCREEN S.A. (BE) 2011-12-08 WO disclosed
EP-1089964-B1 HYDRAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2003-10-29 EP disclosed
EP-0993442-B1 HYDRAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2003-04-23 EP disclosed
US-6239151-B1 TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES, OSTEOARTHRITIS, RESPIRATORY DISEASES, TUMORS, CACHEXIA, CARDIOVASCULAR DISEASES, FEVER, HAEMORRHAGE AND SEPSIS, HYDRAZINE DERIVATIVES, HOFFMANN-LA ROCHE INC. 2001-05-29 US disclosed
US-6235787-B1 ANTIINFLAMMATORY AGENTS; RHEUMATIC DISEASES; BONE DISORDERS; SKIN DISORDERS; MULTIPLE SCLEROSIS HOFFMANN-LA ROCHE INC. 2001-05-22 US disclosed
EP-1089964-A1 HYDRAZINE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2001-04-11 EP disclosed
US-6066662-A USE IN CONTROL OR PREVENTION OF RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS OR IN THE TREATMENT OF INVASIVE TUMOURS, ATHEROSCLEROSIS OR MULTIPLE SCLEROSIS HOFFMANN-LA ROCHE INC. (US) 2000-05-23 US disclosed
WO-2000000465-A1 HYDRAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2000-01-06 WO disclosed